Triazinylaminostilbene compounds
    1.
    发明授权
    Triazinylaminostilbene compounds 失效
    三嗪基氨基芪化合物

    公开(公告)号:US6153122A

    公开(公告)日:2000-11-28

    申请号:US081427

    申请日:1998-05-19

    摘要: The present invention provides a hydrate of the 4,4'-di-triazinylamino-2,2'-di-sulfostilbene compound having the formula: ##STR1## in which M and M.sub.1 independently represent hydrogen, an alkaline-, an alkaline earth metal or ammonium, x is a number within the range of from 1 to 30, and the crystal form of the hydrate (I) being characterized by an X-ray diffraction pattern which is essentially as set out in the accompanying FIGS. 1 to 11; or a mixture containing one or more of the hydrates of the 4,4'-di-triazinylamino-2,2'-di-sulfostilbene compound having the formula (I); processes for the preparation of the new hydrates; and the use of the new hydrates for the preparation of concentrated aqueous formulations of fluorescent whitening agents.

    摘要翻译: 本发明提供了具有下式的4,4'-二 - 三嗪基氨基-2,2'-二磺基芪化合物的水合物:其中M和M1独立地表示氢,碱金属,碱土金属或铵, x是1至30范围内的数字,并且水合物(I)的晶体形式的特征在于X射线衍射图,其基本上如附图中所示。 1至11; 或含有一种或多种具有式(I)的4,4'-二 - 三嗪基氨基-2,2'-二磺基芪化合物的水合物的混合物; 新水合物的制备过程; 以及使用新的水合物来制备荧光增白剂的浓缩水性制剂。

    Triazinylaminostilbene compounds
    2.
    发明授权
    Triazinylaminostilbene compounds 有权
    三嗪基氨基芪化合物

    公开(公告)号:US06331626B1

    公开(公告)日:2001-12-18

    申请号:US09666768

    申请日:2000-09-21

    IPC分类号: C07D25170

    摘要: The present invention provides a hydrate of the 4,4′-di-triazinylamino-2,2′-di-sulfostilbene compound having the formula: in which M and M1 independently represent hydrogen, an alkaline-, an alkaline earth metal or ammonium, x is a number within the range of from 1 to 30, and the crystal form of the hydrate (I) being characterised by an X-ray diffraction pattern which is essentially as set out in the accompanying FIGS. 1 to 11; or a mixture containing one or more of the hydrates of the 4,4′-di-triazinylamino-2,2′-di-sulfostilbene compound having the formula (I); processes for the preparation of the new hydrates; and the use of the new hydrates for the preparation of concentrated aqueous formulations of fluorescent whitening agents.

    摘要翻译: 本发明提供了具有下式的4,4'-二 - 三嗪基氨基-2,2'-二磺基芪化合物的水合物:其中M和M1独立地表示氢,碱金属,碱土金属或铵, x是1至30范围内的数字,并且水合物(I)的晶体形式的特征在于X射线衍射图,其基本上如附图中所示。 1至11; 或含有一种或多种具有式(I)的4,4'-二 - 三嗪基氨基-2,2'-二磺基芪化合物的水合物的混合物; 新水合物的制备过程; 以及使用新的水合物来制备荧光增白剂的浓缩水性制剂。

    Dicyclanil polymorphs and hydrates and their preparation
    4.
    发明授权
    Dicyclanil polymorphs and hydrates and their preparation 有权
    二环兰多晶型物和水合物及其制备方法

    公开(公告)号:US06255316B1

    公开(公告)日:2001-07-03

    申请号:US09486105

    申请日:2000-02-22

    IPC分类号: A61K31505

    CPC分类号: A01N43/54 C07D239/50

    摘要: The present invention relates to several new, polymorphous crystal forms of Dicyclanil, and hydrates and solvates thereof, as well as the preparation thereof. In particular, the invention relates to substantially pure crystal forms of Dicyclanil, having characteristic lattice structures, which are effective for the control of insects and ectoparasites.

    摘要翻译: 本发明涉及一些新的多环结晶形式的双环烯烃,以及它们的水合物和溶剂合物,以及其制备方法。 特别地,本发明涉及具有特征晶格结构的Dicyclanil的基本上纯的晶体形式,其对昆虫和外寄生物的控制是有效的。